Interleukin-18 bioactivity: A novel target for immunopharmacological anti-inflammatory intervention

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 63-71

  Mühl, Heiko ^a   Pfeilschifter, Josef ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Caspase 1; Inflammation; Interleukin 1 ; Interleukin 18; Interleukin 18 binding protein

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN;

ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DRUG TARGETING; HUMAN; IMMUNOPHARMACOLOGY; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHRONIC DISEASE; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; INTERLEUKIN-18;

EID: 4644308152     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.012     Document Type: Review

References (114)

1. L. Agostini, F. Martinon, K. Burns, M.F. McDermott, P.N. Hawkins, and J. Tschopp NALP-3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 20 2004 319 325
2. Y. Aizawa, K. Akita, M. Taniai, K. Torigoe, T. Mori, Y. Nishida, S. Ushio, Y. Nukada, T. Tanimoto, H. Ikegami, M. Ikeda, and M. Kurimoto Cloning and expression of interleukin-18 binding protein FEBS Lett. 445 1999 338 342
3. K. Akita, T. Ohtsuki, Y. Nukada, T. Tanimoto, M. Namba, T. Okura, R. Takakura-Yamamoto, K. Torigoe, Y. Gu, M.S. Su, M. Fujii, M. Satoh-Itoh, K. Yamamoto, K. Kohno, M. Ikeda, and M. Kurimoto Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells J. Biol. Chem. 272 1997 26595 26603
4. M.G. Alexandrakis, F.H. Passam, K. Sfiridaki, J. Moschandrea, C. Pappa, D. Liapi, E. Petreli, P. Roussou, and D.S. Kyriakou Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival Leuk. Res. 28 2004 259 266
5. N.K. Banda, A. Vondracek, D. Kraus, C.A. Dinarello, S.H. Kim, A. Bendele, G. Senaldi, and W.P. Arend Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein J. Immunol. 170 2003 2100 2105
6. K. Barbulescu, C. Becker, J.F. Schlaak, E. Schmitt, K.H. Meyer zum Buschenfelde, and M.F. Neurath IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes J. Immunol. 15 160 1998 3642 3647
7. J.F. Bazan, J.C. Timans, and R.A. Kastelein A newly defined interleukin-1? Nature 379 1996 591
8. R. Cao, J. Farnebo, M. Kurimoto, and Y. Cao Interleukin-18 acts as an angiogenesis and tumor suppressor FASEB J. 13 1999 2195 2202
9. M.T. Carrascal, L. Mendoza, M. Valcarcel, C. Salado, E. Egilegor, N. Telleria, F. Vidal-Vanaclocha, and C.A. Dinarello Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium Cancer Res. 63 2003 491 497
10. A. Colomar, V. Marty, C. Medina, C. Combe, P. Parnet, and T. Amedee Maturation and release of interleukin-1β by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors J. Biol. Chem. 278 2003 30732 30740
11. J.F. Colombel, E.V. Loftus Jr., W.J. Tremaine, L.J. Egan, W.S. Harmsen, C.D. Schleck, A.R. Zinsmeister, and W.J. Sandborn The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients Gastroenterology 126 2004 19 31
12. A. Corbaz, T. ten Hove, S. Herren, P. Graber, B. Schwartsburd, I. Belzer, J. Harrison, T. Plitz, M.H. Kosco-Vilbois, S.H. Kim, C.A. Dinarello, D. Novick, S. van Deventer, and Y. Chvatchko IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease J. Immunol. 168 2002 3608 3616
13. E.M. Creagh, H. Conroy, and S.J. Martin Caspase-activation pathways in apoptosis and immunity Immunol. Rev. 193 2003 10 21
14. G. Cunnane, A. Madigan, E. Murphy, O. FitzGerald, and B. Bresnihan The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis Rheumatology (Oxf.) 40 2001 62 69
15. G. Cunnane, M. Doran, and B. Bresnihan Infections and biological therapy in rheumatoid arthritis Best. Pract. Res., Clin. Rheumatol. 17 2003 345 363
16. T. Dao, K. Ohashi, T. Kayano, M. Kurimoto, and H. Okamura Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells Cell. Immunol. 173 1996 230 235
17. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095 2147
18. C.A. Dinarello Anti-cytokine therapeutics and infections Vaccine 21 Suppl. 2 2003 S24 S34
19. C.A. Dinarello, and G. Fantuzzi Interleukin-18 and host defense against infection J. Infect. Dis. 187 Suppl. 2 2003 S370 S384
20. F. Di Virgilio, P. Chiozzi, S. Falzoni, D. Ferrari, J.M. Sanz, V. Venketaraman, and O.R. Baricordi Cytolytic P2X purinoceptors Cell Death Differ. 5 1998 191 199
21. H. Dong, N. Toyoda, H. Yoneyama, M. Kurachi, T. Kasahara, Y. Kobayashi, H. Inadera, S. Hashimoto, and K. Matsushima Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system Biochem. Biophys. Res. Commun. 298 2002 675 686
22. G. Fantuzzi, and C.A. Dinarello Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1) J. Clin. Immunol. 19 1999 1 11
23. G. Fantuzzi, G. Ku, M.W. Harding, D.J. Livingston, J.D. Sipe, K. Kuida, R.A. Flavell, and C.A. Dinarello Response to local inflammation of interleukin-1β-converting enzyme- deficient mice J. Immunol. 158 1997 1818 1824
24. C. Gabay Cytokine inhibitors in the treatment of rheumatoid arthritis Expert Opin. Biol. Ther. 2 2002 135 149
25. S. Gangemi, R.A. Merendino, F. Guarneri, P.L. Minciullo, G. DiLorenzo, M. Pacor, and S.P. Cannavo Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations J. Eur. Acad. Dermatol. Venereol. 17 2003 42 46
26. L. Garrison, and N.D. McDonnell Etanercept: therapeutic use in patients with rheumatoid arthritis Ann. Rheum. Dis. 58 Suppl. 1 1999 I65 I69
27. S. Gatti, J. Beck, G. Fantuzzi, T. Bartfai, and C.A. Dinarello Effect of interleukin-18 on mouse core body temperature Am. J. Physiol. 282 2002 R702 R709
28. N. Gerdes, G.K. Sukhova, P. Libby, R. Reynolds, J.L. Young, and U. Schönbeck Expression of interleukin (IL)-18 and functional IL-18 receptor an human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis J. Exp. Med. 195 2002 245 257
29. J.J. Gomez-Reino, L. Carmona, V.R. Valverde, E.M. Mola, M.D. Montero BIOBADASER Group Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report Arthritis Rheum. 48 2003 2122 2127
30. J.A. Gracie, S.E. Robertson, and I.B. McInnes Interleukin-18 J. Leukoc. Biol. 73 2003 213 224
31. S.R. Grobmyer, E. Lin, S.F. Lowry, D.E. Rivadeneira, S. Potter, P.S. Barie, and C.F. Nathan Elevation of IL-18 in human sepsis J. Clin. Immunol. 20 2000 212 215
32. N. Günel, U. Coskun, B. Sancak, U. Gunel, O. Hasdemir, and S. Bozkurt Clinical importance of serum IL-18 and nitric oxide activities in breast carcinoma patients Cancer 95 2002 663 667
33. Y. Hamon, M.F. Luciani, F. Becq, B. Verrier, A. Rubartelli, and G. Chimini Interleukin-1β secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1 Blood 90 1997 2911 2915
34. E.W. Humke, S.K. Shriver, M.A. Starovasnik, W.J. Fairbrother, and V.M. Dixit ICEBERG: a novel inhibitor of interleukin-1β generation Cell 103 2000 99 111
35. B.D. Humphreys, and G.R. Dubyak Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line J. Immunol. 157 1996 5627 5637
36. C.A. Hunter, J. Timans, P. Pisacane, S. Menon, G. Cai, W. Walker, M. Aste-Amezaga, R. Chizzonite, J.F. Bazan, and R.A. Kastelein Comparison of the effects of interleukin-1α, interleukin-1β and interferon-γ- inducing factor on the production of interferon-γ by natural killer Eur. J. Immunol. 27 1997 2787 2792
37. V. Hurgin, D. Novick, and M. Rubinstein The promoter of IL-18 binding protein: activation by an IFN-γ-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein-β Proc. Natl. Acad. Sci. U. S. A. 99 2002 16957 16962
38. M. Irmler, S. Hertig, H.R. MacDonald, R. Sadoul, J.D. Becherer, A. Proudfoot, R. Solari, and J. Tschopp Granzyme A is an interleukin 1β-converting enzyme J. Exp. Med. 181 1995 1917 1922
39. S. Jander, and G. Stoll Increased serum levels of the interferon-γ-inducing cytokine interleukin-18 in myasthenia gravis Neurology 59 2002 287 289
40. J.M. Kahlenberg, and G.R. Dubyak Mechanisms of Caspase-1 Activation by P2X7 Receptor-Mediated K+ Release Am. J. Physiol. 286 2004 C1100 C1108
41. H. Kämpfer, H. Mühl, M. Manderscheid, U. Kalina, D. Kauschat, J. Pfeilschifter, and S. Frank Regulation of interleukin-18 expression in keratinocytes (HaCaT): implications for early wound healing Eur. Cytokine Netw. 11 2000 626 633
42. T. Kanai, M. Watanabe, A. Okazawa, T. Sato, M. Yamazaki, S. Okamoto, H. Ishii, T. Totsuka, R. Iiyama, R. Okamoto, M. Ikeda, M. Kurimoto, K. Takeda, S. Akira, and T. Hibi Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease Gastroenterology 121 2001 875 888
43. M. Kawashima, M. Yamamura, M. Taniai, H. Yamauchi, T. Tanimoto, M. Kurimoto, S. Miyawaki, T. Amano, T. Takeuchi, and H. Makino Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease Arthritis Rheum. 44 2001 550 560
44. S.H. Kim, M. Eisenstein, L. Reznikov, G. Fantuzzi, D. Novick, M. Rubinstein, and C.A. Dinarello Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18 Proc. Natl. Acad. Sci. U. S. A. 97 2000 1190 1195
45. H. Kohka, T. Yoshino, H. Iwagaki, I. Sakuma, T. Tanimoto, Y. Matsuo, M. Kurimoto, K. Orita, T. Akagi, and N. Tanaka Interleukin-18/interferon-γ- inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells J. Leukoc. Biol. 64 1998 519 527
46. H. Koizumi, K.C. Sato-Matsumura, H. Nakamura, K. Shida, S. Kikkawa, M. Matsumoto, K. Toyoshima, and T. Seya Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes Arch. Dermatol. Res. 293 2001 325 333
47. G. Ku, T. Faust, L.L. Lauffer, D.J. Livingston, and M.W. Harding Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice Cytokine 8 1996 377 386
48. J.M. Labasi, N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M.M. Payette, W. Brissette, J.R. Wicks, L. Audoly, and C.A. Gabel Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response J. Immunol. 168 2002 6436 6445
49. Y. Liu, H. Huang, A. Saxena, and J. Xiang Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors Cancer Gene Ther. 9 2002 533 542
50. F. Loher, C. Bauer, N. Landauer, K. Schmall, B. Siegmund, H.A. Lehr, M. Dauer, M. Schoenharting, S. Endres, and A. Eigler The interleukin-1β- converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation J. Pharmacol. Exp. Ther. 308 2004 583 590
51. O. Ludwiczek, A. Kaser, D. Novick, C.A. Dinarello, M. Rubinstein, W. Vogel, and H. Tilg Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease J. Clin. Immunol. 22 2002 331 337
52. M.L. Lukic, E. Mensah-Brown, X. Wei, A. Shahin, and F.Y. Liew Lack of the mediators of innate immunity attenuate the development of autoimmune diabetes in mice J. Autoimmun. 21 2003 239 246
53. A. MacKenzie, H.L. Wilson, E. Kiss-Toth, S.K. Dower, R.A. North, and A. Surprenant Rapid secretion of interleukin-1β by microvesicle shedding Immunity 15 2001 825 835
54. Z. Mallat, A. Corbaz, A. Scoazec, S. Besnard, G. Leseche, Y. Chvatchko, and A. Tedgui Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability Circulation 104 2001 1598 1603
55. Z. Mallat, A. Corbaz, A. Scoazec, P. Graber, S. Alouani, B. Esposito, Y. Humbert, Y. Chvatchko, and A. Tedgui Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability Circ. Res. 89 2001 E41 E45
56. K. Matsumoto, and K. Kanmatsuse Elevated interleukin-18 levels in the urine of nephritic patients Nephron 88 2001 334 339
57. S. Matsumoto, K. Tsuji-Takayama, Y. Aizawa, K. Koide, M. Takeuchi, T. Ohta, and M. Kurimoto Interleukin-18 activates NF-kappaB in murine T helper type 1 cells Biochem. Biophys. Res. Commun. 234 1997 454 457
58. V.B. Mehta, J. Hart, and M.D. Wewers ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage J. Biol. Chem. 276 2001 3820 3826
59. H. Mizutani, N. Schechter, G. Lazarus, R.A. Black, and T.S. Kupper Rapid and specific conversion of precursor interleukin-1β to an active interleukin-1 species by human mast cell chymase J. Exp. Med. 174 1991 821 825
60. B. Möller, J. Paulukat, M. Nold, M. Behrens, N. Kukoc-Zivojnov, J.P. Kaltwasser, J. Pfeilschifter, and H. Mühl Interferon-γ induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes Rheumatology (Oxf.) 42 2003 442 445
61. H. Mühl, and J. Pfeilschifter Anti-inflammatory properties of pro-inflammatory interferon-γ Int. Immunopharmacol. 3 2003 1247 1255
62. H. Mühl, H. Kämpfer, M. Bosmann, S. Frank, H. Radeke, and J. Pfeilschifter Interferon-γ mediates gene expression of interleukin-18 binding protein in nonleukocytic cells Biochem. Biophys. Res. Commun. 267 2000 960 963
63. H. Mühl, S. Hö;fler, and J. Pfeilschifter Inhibition of lipopolysaccharide/ATP-induced release of interleukin-18 by KN-62 and glyburide Eur. J. Pharmacol. 482 2003 325 328
64. K. Nakamura, H. Okamura, M. Wada, K. Nagata, and T. Tamura Endotoxin-induced serum factor that stimulates γ-interferon production Infect. Immun. 57 1989 590 595
65. K. Nakanishi, T. Yoshimoto, H. Tsutsui, and H. Okamura Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu Cytokine Growth Factor Rev. 12 2001 53 72
66. F. Nicoletti, I. Conget, R. Di Marco, A.M. Speciale, R. Morinigo, K. Bendtzen, and R. Gomis Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes Diabetologia 44 2001 309 311
67. F. Nicoletti, R. Di Marco, K. Mangano, F. Patti, E. Reggio, A. Nicoletti, K. Bendtzen, and A. Reggio Increased serum levels of interleukin-18 in patients with multiple sclerosis Neurology 57 2001 342 344
68. M. Nold, A. Goede, W. Eberhardt, J. Pfeilschifter, and H. Mühl IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNFα blockage and modulation by IL-10 Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 68 75
69. M. Nold, I.A. Hauser, S. Höfler, A. Goede, W. Eberhardt, T. Ditting, H. Geiger, J. Pfeilschifter, and H. Mühl IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole blood Biochem. Pharmacol. 66 2003 505 510
70. D. Novick, S.H. Kim, G. Fantuzzi, L.L. Reznikov, C.A. Dinarello, and M. Rubinstein Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response Immunity 10 1999 127 136
71. D. Novick, B. Schwartsburd, R. Pinkus, D. Suissa, I. Belzer, Z. Sthoeger, W.F. Keane, Y. Chvatchko, S.H. Kim, G. Fantuzzi, C.A. Dinarello, and M. Rubinstein A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18 Cytokine 14 2001 334 342
72. H. Okamura, H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, and K. Hattori Cloning of a new cytokine that induces IFN-γ production by T cells Nature 378 1995 88 91
73. T. Osaki, J.M. Peron, Q. Cai, H. Okamura, P.D. Robbins, M. Kurimoto, M.T. Lotze, and H. Tahara IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects J. Immunol. 160 1998 1742 1749
74. K. Oshikawa, F. Shi, A.L. Rakhmilevich, P.M. Sondel, D.M. Mahvi, and N.S. Yang Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme cDNA Proc. Natl. Acad. Sci. U. S. A. 96 1999 13351 13356
75. F. Pages, V. Lazar, A. Berger, C. Danel, S. Lebel-Binay, F. Zinzindohoue, P. Desreumaux, C. Cellier, N. Thiounn, D. Bellet, P.H. Cugnenc, and W.H. Fridman Analysis of interleukin-18, interleukin-1 converting enzyme (ICE) and interleukin-18-related cytokines in Crohn's disease lesions Eur. Cytokine Netw. 12 2001 97 104
76. J. Paulukat, M. Bosmann, M. Nold, S. Garkisch, H. Kämpfer, S. Frank, J. Raedle, S. Zeuzem, J. Pfeilschifter, and H. Mühl Expression and release of IL-18 binding protein in response to IFN-γ J. Immunol. 167 2001 7038 7043
77. D.G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, and C.A. Gabel ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood J. Immunol. 165 2000 4615 4623
78. J. Pfeilschifter, and H. Mühl Immunopharmacology: anti-inflammatory therapy targeting transcription factors Eur. J. Pharmacol. 375 1999 237 245
79. C. Plater-Zyberk, L.A. Joosten, M.M. Helsen, P. Sattonnet-Roche, C. Siegfried, S. Alouani, F.A. van De Loo, P. Graber, S. Aloni, R. Cirillo, E. Lubberts, C.A. Dinarello, W.B. van Den Berg, and Y. Chvatchko Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis J. Clin. Invest. 108 2001 1825 1832
80. A.J. Puren, G. Fantuzzi, Y. Gu, M.S. Su, and C.A. Dinarello Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells J. Clin. Invest. 101 1998 711 721
81. A.J. Puren, G. Fantuzzi, and C.A. Dinarello Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells Proc. Natl. Acad. Sci. U. S. A. 96 1999 2256 22561
82. X. Que, S.H. Kim, M. Sajid, L. Eckmann, C.A. Dinarello, J.H. McKerrow, and S.L. Reed A surface amebic cysteine proteinase inactivates interleukin-18 Infect. Immun. 71 2003 1274 1280
83. D. Rampe, L. Wang, and G.E. Ringheim P2X7 receptor modulation of β-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia J. Neuroimmunol. 147 2004 56 61
84. J.C. Randle, M.W. Harding, G. Ku, M. Schonharting, and R. Kurrle ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs Expert Opin. Investig. Drugs 10 2001 1207 1209
85. B. Rau, K. Baumgart, A.S. Paszkowski, J.M. Mayer, and H.G. Beger Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum interleukin-18 with pancreatic necrosis and systemic complications Crit. Care Med. 29 2001 1556 1562
86. K. Redlich, G. Schett, G. Steiner, S. Hayer, E.F. Wagner, and J.S. Smolen Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade Arthritis Rheum. 48 2003 3308 3319
87. Y. Sakao, K. Takeda, H. Tsutsui, T. Kaisho, F. Nomura, H. Okamura, K. Nakanishi, and S. Akira Interleukin-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock Int. Immunol. 11 1999 471 480
88. B.E. Sands Therapy of inflammatory bowel disease Gastroenterology 118 Suppl. 1 2000 S68 S82
89. U. Schönbeck, F. Mach, and P. Libby Generation of biologically active interleukin-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of interleukin-1β processing J. Immunol. 161 1998 3340 3346
90. F.D. Shi, K. Takeda, S. Akira, N. Sarvetnick, and H.G. Ljunggren IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ a by NK cells J. Immunol. 165 2000 3099 3104
91. K. Shigehara, N. Shijubo, M. Ohmichi, R. Takahashi, S. Kon, H. Okamura, M. Kurimoto, Y. Hiraga, T. Tatsuno, S. Abe, and N. Sato IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs J. Immunol. 166 2001 642 649
92. B. Siegmund, and M. Zeitz Pralnacasan (vertex pharmaceuticals) IDrugs 6 2003 154 158
93. B. Siegmund, H.A. Lehr, G. Fantuzzi, and C.A. Dinarello IL-1β-converting enzyme (caspase-1) in intestinal inflammation Proc. Natl. Acad. Sci. U. S. A. 98 2001 13249 13254
94. P.V. Sivakumar, G.M. Westrich, S. Kanaly, K. Garka, T.L. Born, J.M. Derry, and J.L. Viney Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage Gut 50 2002 812 820
95. R.L. Smeets, F.A. van de Loo, O.J. Arntz, M.B. Bennink, L.A. Joosten, and W.B. van den Berg Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice Gene Ther. 10 2003 1004 1011
96. R.J. Stuyt, M.G. Netea, S.H. Kim, D. Novick, M. Rubinstein, B.J. Kullberg, J.W. Van der Meer, and C.A. Dinarello Differential roles of interleukin-18 (IL-18) and IL-12 for induction of γ-interferon by staphylococcal cell wall components and superantigens Infect. Immun. 69 2001 5025 5030
97. S. Sugawara, A. Uehara, T. Nochi, T. Yamaguchi, H. Ueda, A. Sugiyama, K. Hanzawa, K. Kumagai, H. Okamura, and H. Takada Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells J. Immunol. 167 2001 6568 6575
98. N. Sugimoto, M. Nakahira, H.J. Ahn, M. Micallef, T. Hamaoka, M. Kurimoto, and H. Fujiwara Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-γ production induced by IL-12 alone or together with IL-18 Eur. J. Immunol. 33 2003 243 251
99. K. Takeda, H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira Defective NK cell activity and Th1 response in IL-18-deficient mice Immunity 8 1998 383 390
100. M. Takeuchi, T. Okura, T. Mori, K. Akita, T. Ohta, M. Ikeda, H. Ikegami, and M. Kurimoto Intracellular production of interleukin-18 in human epithelial-like cell lines is enhanced by hyperosmotic stress in vitro Cell Tissue Res. 297 1999 467 473
101. T. Ten Hove, A. Corbaz, H. Amitai, S. Aloni, I. Belzer, P. Graber, P. Drillenburg, S.J. van Deventer, Y. Chvatchko, and A.A. Te Velde Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNFα production in mice Gastroenterology 121 2001 1372 1379
102. J. Tschopp, F. Martinon, and K. Burns NALPs: a novel protein family involved in inflammation Nat. Rev. Mol., Cell Biol. 4 2003 95 104
103. K. Tsuboi, T. Miyazaki, M. Nakajima, Y. Fukai, N. Masuda, R. Manda, M. Fukuchi, H. Kato, and H. Kuwano Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma Cancer Lett. 205 2004 207 214
104. H. Tsutsui, N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, H. Yagita, H. Okamura, and K. Nakanishi Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice Immunity 11 1999 359 367
105. K.G. Veenstra, Z.L. Jonak, S. Trulli, and J.A. Gollob IL-12 induces monocyte IL-18 binding protein expression via IFN-γ J. Immunol. 168 2002 2282 2287
106. B. Verhaeghe, P. Gevaert, G. Holtappels, K.F. Lukat, B. Lange, P. Van Cauwenberge, and C. Bachert Up-regulation of IL-18 in allergic rhinitis Allergy 57 2002 825 830
107. F. Vidal-Vanaclocha, G. Fantuzzi, L. Mendoza, A.M. Fuentes, M.J. Anasagasti, J. Martin, T. Carrascal, P. Walsh, L.L. Reznikov, S.H. Kim, D. Novick, M. Rubinstein, and C.A. Dinarello IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1 Proc. Natl. Acad. Sci. U. S. A. 97 2000 734 739
108. X.Q. Wei, B.P. Leung, W. Niedbala, D. Piedrafita, G.J. Feng, M. Sweet, L. Dobbie, A.J. Smith, and F.Y. Liew Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice J. Immunol. 163 1999 2821 2828
109. X.Q. Wei, B.P. Leung, H.M. Arthur, I.B. McInnes, and F.Y. Liew Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18 J. Immunol. 166 2001 517 521
110. R.D. Wheeler, E.A. Young, N.J. Rothwell, M.D. Hall, and G.N. Luheshi Up-regulation of IL-18BP, but not IL-18 mRNA in rat liver by LPS Cytokine 21 2003 161 166
111. C.K. Wong, E.K. Li, C.Y. Ho, and C.W. Lam Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus Rheumatology (Oxf.) 39 2000 1078 1081
112. M. Yamamura, M. Kawashima, M. Taniai, H. Yamauchi, T. Tanimoto, M. Kurimoto, Y. Morita, Y. Ohmoto, and H. Makino Interferon-γ-inducing activity of interleukin-18 in the joint with rheumatoid arthritis Arthritis Rheum. 44 2001 275 285
113. A. Yndestad, A.M. Holm, F. Muller, S. Simonsen, S.S. Froland, L. Gullestad, and P. Aukrust Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure Cardiovasc. Res. 60 2003 141 146
114. T. Zhang, K. Kawakami, M.H. Qureshi, H. Okamura, M. Kurimoto, and A. Saito Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of γ-interferon by natural killer cells Infect. Immun. 65 1997 3594 3599